Literature DB >> 7660643

ABO blood group genotype and plasma von Willebrand factor in normal individuals.

M Shima1, Y Fujimura, T Nishiyama, T Tsujiuchi, N Narita, T Matsui, K Titani, M Katayama, F Yamamoto, A Yoshioka.   

Abstract

von Willebrand factor (vWF) is a multimeric plasma protein with ABO (H) blood group sugar chains. We investigated a total of 330 plasmas from normal individuals having various ABO genotypes, with special reference to vWF antigen and its platelet glycoprotein-Ib-related biological activities, termed ristocetin cofactor (RCof) and botrocetin cofactor (BCof). RCof reflects the biological activity of higher vWF multimers, while BCof reflects that of vWF of multimers of all sizes. Plasmas from normal individuals carrying one O gene (genotypes AO and BO) had slightly, but proportionally lower levels of vWF antigen, RCof, and BCof than those carrying no O gene (genotypes AA, AB, and BB). Normal plasmas from individuals carrying two O genes (genotype OO) showed much lower values for these parameters than the other plasmas, as previously reported. However, multimeric analysis of plasma vWF antigen revealed no differences among the different genotypes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7660643     DOI: 10.1111/j.1423-0410.1995.tb02579.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  27 in total

Review 1.  Factoring in Factor VIII With Acute Ischemic Stroke.

Authors:  James E Siegler; Alyana Samai; Karen C Albright; Amelia K Boehme; Sheryl Martin-Schild
Journal:  Clin Appl Thromb Hemost       Date:  2015-02-10       Impact factor: 2.389

2.  Recommendations from the Tuscan Transfusion System on the appropriate use of solvent/detergent-inactivated fresh-frozen plasma.

Authors:  Giancarlo Maria Liumbruno; Maria Laura Sodini; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2008-01       Impact factor: 3.443

3.  Genome-wide studies of von Willebrand factor propeptide identify loci contributing to variation in propeptide levels and von Willebrand factor clearance.

Authors:  A B Ozel; B McGee; D Siemieniak; P M Jacobi; S L Haberichter; L C Brody; J L Mills; A M Molloy; D Ginsburg; J Z Li; K C Desch
Journal:  J Thromb Haemost       Date:  2016-08-19       Impact factor: 5.824

4.  Tissue Factor Expression on Platelet Surface during Preparation and Storage of Platelet Concentrates.

Authors:  Alfonso Vignoli; Cinzia Giaccherini; Marina Marchetti; Cristina Verzeroli; Chiara Gargantini; Luca Da Prada; Barbara Giussani; Anna Falanga
Journal:  Transfus Med Hemother       Date:  2013-03-15       Impact factor: 3.747

Review 5.  Blood group antigens: molecules seeking a function?

Authors:  P Greenwell
Journal:  Glycoconj J       Date:  1997-02       Impact factor: 2.916

6.  Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood type.

Authors:  Birgitte F Sode; Kristine H Allin; Morten Dahl; Finn Gyntelberg; Børge G Nordestgaard
Journal:  CMAJ       Date:  2013-02-04       Impact factor: 8.262

7.  ABO blood group polymorphisms and risk for ischemic stroke and peripheral arterial disease.

Authors:  Adriano de Paula Sabino; Daniel Dias Ribeiro; Caroline Pereira Domingheti; Danyelle Romana Alves Rios; Luci Maria SantAna Dusse; Maria das Graças Carvalho; Ana Paula Fernandes
Journal:  Mol Biol Rep       Date:  2014-01-22       Impact factor: 2.316

8.  Genetic determinants of plasma von Willebrand factor antigen levels: a target gene SNP and haplotype analysis of ARIC cohort.

Authors:  Marco Campos; Wei Sun; Fuli Yu; Maja Barbalic; Weihong Tang; Lloyd E Chambless; Kenneth K Wu; Christie Ballantyne; Aaron R Folsom; Eric Boerwinkle; Jing-Fei Dong
Journal:  Blood       Date:  2011-02-22       Impact factor: 22.113

9.  Aberrant expression of histo-blood group A type 3 antigens in vascular endothelial cells in inflammatory sites.

Authors:  Mizuho Nosaka; Yuko Ishida; Aki Tanaka; Takahito Hayashi; Tomoko Miyashita; Chikako Kaminaka; Wolfgang Eisenmenger; Fukumi Furukawa; Akihiko Kimura
Journal:  J Histochem Cytochem       Date:  2007-11-12       Impact factor: 2.479

10.  Blood Type O is not associated with increased blood loss in extensive spine surgery.

Authors:  Ryu Komatsu; Jarrod E Dalton; Michael Ghobrial; Alexander Y Fu; Jae H Lee; Cameron Egan; Daniel I Sessler; Yusuke Kasuya; Alparslan Turan
Journal:  J Clin Anesth       Date:  2014-08-27       Impact factor: 9.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.